Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy

Fig. 2

The improvement in cerebral atrophy in follow-up after autologous OM-MSC treatment. A T1-weighted cerebral MRI showing in 2015, 2018, and normal control. B T2-FLAIR cerebral MRI showing in 2015, 2018, and normal control. C The automatic brain tissue segmentation imaging showing in 2015, 2018, and normal control, white matters (blue), gray matters (red), CSF (green). Normal control represented a healthy 26-year-old female cerebral MRI. D–G Representative data demonstrating brain anatomy images and cerebral tissue segmentation results obtained from 1-year follow-up in 2015 and 4-year follow-up in 2018. D Total cerebral volume (TCV) increased by 0.98% from 2015 to 2018. E White matter volume increased by 7.54% from 2015 to 2018. F Gray matter volume increased by 6.81% from 2015 to 2018. G CFS volume decreased by 10.76% from 2015 to 2018. Normal control represented a healthy 26-year-old female cerebral volume

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512